| 34091506 | The Impact of Adjuvant Hemithoracic Radiation on Outcomes in Patients With Stage I-III Malignant Pleural Mesothelioma: A Dual Registry Analysis. | Ann Surg | 2023 |
| 37051915 | Immune Phenotype and Postoperative Complications After Elective Surgery. | Ann Surg | 2023 |
| 36455397 | Sins of omission: A meta-research study evaluating the omission of operability in published retrospective comparisons of surgery with stereotactic body radiotherapy in patients with early-stage non-small cell lung cancer. | Lung Cancer | 2023 |
| 36040026 | The Effect of Center Esophagectomy Volume on Outcomes in Clinical Stage I to III Esophageal Cancer. | Ann Surg | 2023 |
| 32209899 | The Impact of Adjuvant Therapy on Survival After Esophagectomy for Node-negative Esophageal Adenocarcinoma. | Ann Surg | 2022 |
| 33857493 | Impact of Time to Endoscopic Resection on Outcomes for Stage I Esophageal Adenocarcinoma. | Ann Thorac Surg | 2022 |
| 35258509 | A Multidimensional Bioinformatic Platform for the Study of Human Response to Surgery. | Ann Surg | 2022 |
| 34819266 | Design and Rationale for a Phase III, Double-Blind, Placebo-Controlled Study of Neoadjuvant Durvalumab⿯+⿯Chemotherapy Followed by Adjuvant Durvalumab for the Treatment of Patients With Resectable Stages II and III non-small-cell Lung Cancer: The AEGEAN Trial. | Clin Lung Cancer | 2022 |
| 33985811 | Perioperative outcomes of pulmonary resection after neoadjuvant pembrolizumab in patients with non-small cell lung cancer. | J Thorac Cardiovasc Surg | 2022 |
| 33417330 | Tumor Size, Histology, and Survival After Stereotactic Ablative Radiotherapy and Sublobar Resection in Node-negative Non-small Cell Lung Cancer. | Ann Surg | 2022 |
| 32649467 | The Relationship Between Lymph Node Ratio and Survival Benefit With Adjuvant Chemotherapy in Node-positive Esophageal Adenocarcinoma. | Ann Surg | 2022 |
| 32327184 | The effect of extent of resection on outcomes in patients with limited stage small cell lung cancer. | J Thorac Cardiovasc Surg | 2021 |
| 33494946 | Complications after Ravitch versus Nuss repair of pectus excavatum: A Society of Thoracic Surgeons (STS) General Thoracic Surgery Database analysis. | Surgery | 2021 |
| 33223192 | Divided by an ocean of water but united in an ocean of uncertainty: A transatlantic review of mesothelioma surgery guidelines. | J Thorac Cardiovasc Surg | 2021 |
| 33223138 | Divided by an Ocean of Water but United in an Ocean of Uncertainty: A Transatlantic Review of Mesothelioma Surgery Guidelines. | Ann Thorac Surg | 2021 |
| 33395697 | Divided by an ocean of water but united in an ocean of uncertainty: a transatlantic review of mesothelioma surgery guidelines. | Eur J Cardiothorac Surg | 2021 |
| 32858216 | Perioperative Outcomes and 5-year Survival After Open versus Thoracoscopic Sleeve Resection for Lung Cancer. | Semin Thorac Cardiovasc Surg | 2021 |
| 32681837 | Patterns of Use of Induction Therapy for T2N0 Esophageal Cancer. | Ann Thorac Surg | 2021 |
| 32853569 | Impact of Age on Surgical Outcomes for Locally Advanced Esophageal Cancer. | Ann Thorac Surg | 2021 |
| 32652096 | The Effect of Tumor Size and Histologic Findings on Outcomes After Segmentectomy vs Lobectomy for Clinically Node-Negative Non-Small Cell Lung Cancer. | Chest | 2021 |
| 32433987 | The Quality of Peer-Reviewed Publications on Surgery for Early Stage Lung Cancer Within the Veterans Health Administration. | Semin Thorac Cardiovasc Surg | 2020 |
| 31928824 | The effect of age on survival after endoscopic resection versus surgery for T1a esophageal cancer. | J Thorac Cardiovasc Surg | 2020 |
| 31926400 | The Role of Adjuvant Therapy in Patients With Margin-Positive (R1) Esophagectomy: A National Analysis. | J Surg Res | 2020 |
| 31924363 | Disparities in guideline-concordant treatment for node-positive, non-small cell lung cancer following surgery. | J Thorac Cardiovasc Surg | 2020 |
| 32011691 | The Role of Neoadjuvant Chemotherapy in Patients With Resectable Malignant Pleural Mesothelioma-An Institutional and National Analysis. | J Natl Cancer Inst | 2020 |
| 31740115 | Effect of time to surgery on outcomes in stage I esophageal adenocarcinoma. | J Thorac Cardiovasc Surg | 2020 |
| 31706554 | The influence of adjuvant therapy on survival in patients with indeterminate margins following surgery for non-small cell lung cancer. | J Thorac Cardiovasc Surg | 2020 |
| 33097982 | Stellate Ganglion Blockade: an Intervention for the Management of Ventricular Arrhythmias. | Curr Hypertens Rep | 2020 |
| 32717408 | Multi-Institutional Prospective Validation of Prognostic mRNA Signatures in Early Stage Squamous Lung Cancer (Alliance). | J Thorac Oncol | 2020 |
| 32622794 | Patterns of Care in Neoadjuvant Chemoradiotherapy for Node-Positive Esophageal Adenocarcinoma. | Ann Thorac Surg | 2020 |
| 32340682 | Reply to Waller et al. Standardizing Surgical Treatment for Mesothelioma. | J Thorac Oncol | 2020 |
| 32330471 | The Effect of Timing of Adjuvant Therapy on Survival After Esophagectomy. | Ann Thorac Surg | 2020 |
| 32439042 | Stellate Ganglion Blockade for the Treatment of Refractory Ventricular Arrhythmias. | JACC Clin Electrophysiol | 2020 |
| 32544452 | Effect of Lymph Node Assessment on Outcomes in Surgery for Limited Stage Small Cell Lung Cancer. | Ann Thorac Surg | 2020 |
| 28799982 | A National Analysis of Long-term Survival Following Thoracoscopic Versus Open Lobectomy for Stage I Non-small-cell Lung Cancer. | Ann Surg | 2019 |
| 30253973 | Correlation of PD-L1 Expression with Tumor Mutation Burden and Gene Signatures for Prognosis in Early-Stage Squamous Cell Lung Carcinoma. | J Thorac Oncol | 2019 |
| 31557535 | Outcomes for Surgery in Large Cell Lung Neuroendocrine Cancer. | J Thorac Oncol | 2019 |
| 31470129 | Radiologic Considerations and Standardization of Malignant Pleural Mesothelioma Imaging Within Clinical Trials: Consensus Statement from the NCI Thoracic Malignancy Steering Committee - International Association for the Study of Lung Cancer - Mesothelioma Applied Research Foundation Clinical Trials Planning Meeting. | J Thorac Oncol | 2019 |
| 31356800 | Surgery Is Associated With Survival Benefit in T4a Esophageal Adenocarcinoma: A National Analysis. | Ann Thorac Surg | 2019 |
| 31606169 | Outcomes of surgery versus chemoradiotherapy in patients with clinical or pathologic stage N3 non-small cell lung cancer. | J Thorac Cardiovasc Surg | 2019 |
| 31260832 | Pathologic Considerations and Standardization in Mesothelioma Clinical Trials. | J Thorac Oncol | 2019 |
| 31125736 | The Use of Radiation Therapy for the Treatment of Malignant Pleural Mesothelioma: Expert Opinion from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation. | J Thorac Oncol | 2019 |
| 31004586 | Adjuvant Therapy for Patients With Early Large Cell Lung Neuroendocrine Cancer: AÂ National Analysis. | Ann Thorac Surg | 2019 |
| 31136816 | A Proposed System Toward Standardizing Surgical-Based Treatments for Malignant Pleural Mesothelioma, From the Joint National Cancer Institute-International Association for the Study of Lung Cancer-Mesothelioma Applied Research Foundation Taskforce. | J Thorac Oncol | 2019 |
| 30659888 | A One-Step Autotransplantation Can Facilitate the Excision of Cardiac Tumors Invading the Lung. | Semin Thorac Cardiovasc Surg | 2019 |
| 29258674 | Surgical Outcomes After Neoadjuvant Chemotherapy and Ipilimumab for Non-Small Cell Lung Cancer. | Ann Thorac Surg | 2018 |
| 30229921 | Prevalence and resource utilization for vocal fold paralysis/paresis after esophagectomy. | Laryngoscope | 2018 |
| 30266660 | Current and Future Management of Malignant Mesothelioma: A Consensus Report from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation. | J Thorac Oncol | 2018 |
| 28475559 | Long-term Survival After Surgery Compared With Concurrent Chemoradiation for Node-negative Small Cell Lung Cancer. | Ann Surg | 2018 |
| 29643104 | Actigraphy assessment of sleep quality among patients with acute myeloid leukaemia during induction chemotherapy. | BMJ Support Palliat Care | 2018 |